These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25664790)

  • 1. Structural analysis of ibuprofen binding to human adipocyte fatty-acid binding protein (FABP4).
    González JM; Fisher SZ
    Acta Crystallogr F Struct Biol Commun; 2015 Feb; 71(Pt 2):163-70. PubMed ID: 25664790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands.
    Beniyama Y; Matsuno K; Miyachi H
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1662-6. PubMed ID: 23395658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review.
    Floresta G; Pistarà V; Amata E; Dichiara M; Marrazzo A; Prezzavento O; Rescifina A
    Eur J Med Chem; 2017 Sep; 138():854-873. PubMed ID: 28738306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
    Furuhashi M
    J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022.
    Floresta G; Patamia V; Zagni C; Rescifina A
    Eur J Med Chem; 2022 Oct; 240():114604. PubMed ID: 35849941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR evaluation of adipocyte fatty acid binding protein (aP2) with R- and S-ibuprofen.
    Bai G; Mo H; Shapiro M
    Bioorg Med Chem; 2008 Apr; 16(8):4323-30. PubMed ID: 18375128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenal.
    Hellberg K; Grimsrud PA; Kruse AC; Banaszak LJ; Ohlendorf DH; Bernlohr DA
    Protein Sci; 2010 Aug; 19(8):1480-9. PubMed ID: 20509169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for activation of fatty acid-binding protein 4.
    Gillilan RE; Ayers SD; Noy N
    J Mol Biol; 2007 Oct; 372(5):1246-60. PubMed ID: 17761196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).
    Zhang M; Zhu W; Li Y
    Med Chem; 2014 Jun; 10(4):339-47. PubMed ID: 24024500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the human-heart fatty-acid-binding protein 3 in complex with the fluorescent probe 1-anilinonaphthalene-8-sulphonic acid.
    Hirose M; Sugiyama S; Ishida H; Niiyama M; Matsuoka D; Hara T; Mizohata E; Murakami S; Inoue T; Matsuoka S; Murata M
    J Synchrotron Radiat; 2013 Nov; 20(Pt 6):923-8. PubMed ID: 24121341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, crystallization and structure of human adipocyte lipid-binding protein (aP2).
    Marr E; Tardie M; Carty M; Brown Phillips T; Wang IK; Soeller W; Qiu X; Karam G
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Nov; 62(Pt 11):1058-60. PubMed ID: 17077479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural properties of the adipocyte lipid binding protein.
    Reese-Wagoner A; Thompson J; Banaszak L
    Biochim Biophys Acta; 1999 Nov; 1441(2-3):106-16. PubMed ID: 10570239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into ligand binding features of dual FABP4/5 inhibitors by molecular dynamics simulations.
    Wu W; Han L; Wang C; Wen X; Sun H; Yuan H
    J Biomol Struct Dyn; 2019 Nov; 37(18):4790-4800. PubMed ID: 30590992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid binding to the human transport proteins FABP3, FABP4, and FABP5 from a Ligand's perspective.
    Michler S; Schöffmann FA; Robaa D; Volmer J; Hinderberger D
    J Biol Chem; 2024 Jun; 300(6):107396. PubMed ID: 38777142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, crystallization and preliminary X-ray diffraction analysis of two intestinal fatty-acid binding proteins in the presence of 11-(dansylamino)undecanoic acid.
    Laguerre A; Wielens J; Parker MW; Porter CJ; Scanlon MJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):291-5. PubMed ID: 21301109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure and backbone dynamics of human liver fatty acid binding protein: fatty acid binding revisited.
    Cai J; Lücke C; Chen Z; Qiao Y; Klimtchuk E; Hamilton JA
    Biophys J; 2012 Jun; 102(11):2585-94. PubMed ID: 22713574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concerted dynamic motions of an FABP4 model and its ligands revealed by microsecond molecular dynamics simulations.
    Li Y; Li X; Dong Z
    Biochemistry; 2014 Oct; 53(40):6409-17. PubMed ID: 25231537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5.
    Yan F; Liu X; Zhang S; Su J; Zhang Q; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of nonsteroidal anti-inflammatory drugs to Abeta fibril.
    Takeda T; Chang WE; Raman EP; Klimov DK
    Proteins; 2010 Oct; 78(13):2849-60. PubMed ID: 20635343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.
    Floresta G; Gentile D; Perrini G; Patamia V; Rescifina A
    Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31683588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.